Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Yin

Showing results (271-280 of 273) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 273 results.
Physical Review Letters|May 21, 2005
Body-centered-cubic Ni and its magnetic propertiesC S Tian, D Qian, D Wu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 11, 2024
[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study]Z H Liu, Q L Jin, Y X Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 11, 2024
[Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial]Z H Liu, Q L Jin, Y X Zhang, et al.
Pageof 28

Showing results (271-280 of 273) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 273 results.
Physical Review Letters|May 21, 2005
Body-centered-cubic Ni and its magnetic propertiesC S Tian, D Qian, D Wu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 11, 2024
[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study]Z H Liu, Q L Jin, Y X Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 11, 2024
[Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial]Z H Liu, Q L Jin, Y X Zhang, et al.
Pageof 28